Intrinsic Value of S&P & Nasdaq Contact Us

Evolus, Inc. EOLS NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
57/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$15.00
+237.8%

Stock Statistics — EOLS

Evolus, Inc. (EOLS) has a market capitalization of $288.87M and trades at $4.44. The 52-week range is 3.86-12.28.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -5.6, Earnings Per Share (EPS) of $-0.80, annual revenue of $297.18M.

The stock has a beta of 1.00, operates in the Healthcare sector.

Trading Data
Current Price$4.44
52-Week Range3.86-12.28
Volume720.85K
Avg Volume (30D)1.18M
Market Cap$288.87M
Beta (1Y)1.00
Company
IPO Date2018-02-08
Employees372
CEODavid Moatazedi
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS30052C1071
CUSIP30052C107
Income (Latest Year)
Revenue$297.18M
Gross Profit$192.76M
EBITDA$-28.86M
Operating Income$-37.6M
Net Income$-51.64M
EPS$-0.80
EPS Diluted$-0.80
Shares Outstanding$64.47M
Balance Sheet (Latest Year)
Total Assets$225.87M
Current Assets$142.92M
Cash & ST Investments$53.83M
Total Liabilities$248.97M
Total Debt$155M
Net Debt$101.17M
Total Equity$-23.11M
Debt / Equity-6.71
Valuation Ratios
P/E Ratio-5.6
P/S Ratio0.97
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message